Deardorf Caren bought CRNX
June 7, 2024 · Form 4 insider transaction
Deardorf Caren bought 12,500 shares of Crinetics Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderDeardorf Caren
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 7, 2024
Filing dateJune 11, 2024
Shares owned after12,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.